Table 2.

Outcomes for patients treated with chemohormonal therapy (CHT) and RP (N=34) compared with patients eligible for enrollment in the CHT trial but underwent RP only (N=123). Because of imbalances in the two groups the CHT were also compared to a subset of the comparison group at the top 30% of the Kattan risk score (N=37).

Outcome	Comparison Group	Cox Proportional Hazard Model			5-yr Logistic Regression Model
		HR	95% CI	p-value	OR	95% CI	p-value
BCR	Complete	0.76	0.43, 1.34	0.3	1.02	0.35, 2.95	1
BCR	High-risk only	0.83	0.47, 1.48	0.5	1.42	0.46, 4.40	0.5
Metastatic Disease	Complete	0.55	0.24, 1.29	0.2	0.37	0.10, 1.31	0.12
Metastatic Disease	High-risk only	0.59	0.25, 1.41	0.2	0.43	0.12, 1.47	0.2
Overall Death	Complete	0.98	0.41, 2.35	1	0.42	0.07, 2.62	0.4
Overall Death	High-risk only	0.99	0.40, 2.45	1	0.41	0.07, 2.32	0.3

* BCR = Biochemical Recurrence